Molecular biomarkers for the evaluation of lung nodules

The goal of evaluating someone with a lung nodule is to accelerate treatment when the nodule is an early-stage lung cancer and to minimise testing when the nodule is benign. Promising advances in lung nodule diagnostics have the potential to improve our current management options. Thoughtful consideration of when and how to apply these tests is necessary to ensure that their use leads to more benefit than harm.